Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform

Published:2022-04-05 Issue:6 Volume:30 Page:589-602
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Ghaemi Shokoofeh¹,Fekrirad Zahra¹²,Zamani Nina¹,Rahmani Rana¹,Arefian Ehsan¹³

Affiliation:

1. Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran;

2. Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran;

3. Pediatric Cell and Gene Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran

Funder

University of Tehran

National Institute for Medical Research Development

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2022.2047191

Reference205 articles.

1. Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets

2. Glioblastoma multiforme: Pathogenesis and treatment

3. Effective treatment of glioblastoma requires crossing the blood–brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging roles of circHECTD1 in human diseases and the specific underlying regulatory mechanisms;PeerJ;2024-06-24

2. Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities;Pathology - Research and Practice;2024-01

3. Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review;Pathology - Research and Practice;2023-12

4. The Spectrum of Molecular Pathways in Gliomas—An Up-to-Date Review;Biomedicines;2023-08-16

5. The long non-coding RNA keratin-7 antisense acts as a new tumor suppressor to inhibit tumorigenesis and enhance apoptosis in lung and breast cancers;Cell Death & Disease;2023-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3